Chris Lloyd is a highly experienced professional in the field of cell-based screening, currently serving as the Director of Cell Based Screening at Revvity since May 2023. Prior to this role, Chris held various positions at Horizon Discovery from December 2010 to May 2023, including Director of Cell Based Screening and Cell Services Manager. Earlier in the career, Chris worked at the Wellcome Trust Sanger Institute as a Research Assistant for the cancer genome project and served as a DNA analyst at the Forensic Science Service. Chris also gained experience as a Scientist in compound management at GlaxoSmithKline. Educational credentials include a 2:1 degree in forensic science from the University of Central Lancashire, obtained between 2004 and 2007.
This person is not in any teams
This person is not in any offices